Arena Pharmaceuticals Appoints Biotech Executive Katharine Knobil, M.D., to Board of Directors
Arena Pharmaceuticals, Inc.(Nasdaq: ARNA) today announced the appointment of Dr. Katharine Knobil to the Company's Board of Directors. Dr. Knobil brings more than 20 years of leadership and expertise across a range of areas including global clinical development, health outcomes and medical affairs.
"Dr. Knobil has a wealth of pharmaceutical experience that spans across all phases of research and clinical development. She has an established record of growing and leading su...